FDA approves injectable drug for three infections
The US Food and Drug Administration has approved injectable drug ceftobiprole medocaril sodium (Zevtera) for treatment of Staphylococcus aureus bacteremia (SAB) among adults. Ceftobiprole, a pyrrolidinone cephalosporin antibiotic, is active moiety of the prodrug ceftobiprole medocaril. It is indicated for people with right-sided infective endocarditis, acute bacterial skin and skin structure infections (ABSSSI), and community-acquired […]